Stay updated on Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in HAE Clinical Trial page.

Latest updates to the Lanadelumab in HAE Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry v3.3.3 was added to the history, and the HHS Vulnerability Disclosure and revision v3.3.2 were removed from the history.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new site revision label 'v3.3.2' is shown on the page, replacing the previous 'v3.3.1'. This update does not alter study data, page content, or required actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision v3.3.1 was added and v3.2.0 was removed from the record history, and these changes affect only revision history metadata and do not alter the study data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the notice about a lapse in government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check69 days agoChange DetectedThe old and new screenshots show the same record history content; only minor UI/layout differences are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference12%

Stay in the know with updates to Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in HAE Clinical Trial page.